Awards Nomination 20+ Million Readerbase
PMC/PubMed Indexed Articles

Development of Secreted Protein and Acidic and Rich in Cysteine (SPARC) Targeted Nanoparticles for the Prognostic Molecular Imaging of Metastatic Prostate Cancer

The Highs and Lows of FAIMS: Predictions and Future Trends for High Field Asymmetric Waveform Ion Mobility Spectrometry

View More »

Google Scholar citation report
Citations : 8261

Journal of Nanomedicine & Nanotechnology received 8261 citations as per Google Scholar report

Flyer image
Journal of Nanomedicine & Nanotechnology peer review process verified at publons
Flyer image
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Scimago
  • Ulrich's Periodicals Directory
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • MIAR
  • Scientific Indexing Services (SIS)
  • Euro Pub
  • Google Scholar
View More
Useful Links
Share This Page
Journal Flyer
Flyer image
Open Access Journals
View More

Rutledge G Ellis-Behnke

Rutledge G Ellis-Behnke

Director Nanomedicine Translational Think Tank Department of Ophthalmology Ruprecht-Karls-University Heidelberg, Germany

Biography
Rutledge Ellis-Behnke is Professor at the University of Heidelberg Mannheim Faculty of Medicine, where he is the Director of the Nanomedicine Translational Think Tank. In addition he is Research Affiliate in the Brain and Cognitive Sciences department at the Massachusetts Institute of Technology. Previously he was Associate Director of the Technology Transfer Office and Associate Professor in the Faculty of Medicine at the University of Hong Kong. He received his PhD from MIT in Neuroscience BSc from Rutgers University and graduated from Harvard Business School’s International Senior Manager’s Program AMP/ISMP. Prior to returning to school to pursue his PhD EllisBehnke held various management positions including Senior Vice President of Huntingdon a public company for testing and consulting services and Cofounder/CEO in 1995 of one of the first internet companies to do online commerce.
Research Interest
His primary research is focused on reconnecting the disconnected parts of the brain—with the goal of being able to provide a prescription to restore quality of life after brain or spinal cord trauma, or stroke and Nanomaterial and Nanotechnology applications in Medical therapy.